Ownership

Gain Therapeutics, Inc. Ownership

Ownership for Gain Therapeutics, Inc. (GANX) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteGANXOwnership/analysis/GANX/ownership

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GANX.

Stock profile

Ticker

GANX

Asset type

Stock

Market cap

$80.2M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Gain Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • GANX primary listing

Research sections

Valuation

Review valuation context for Gain Therapeutics, Inc..

Future growth

Review future growth context for Gain Therapeutics, Inc..

Past performance

Review past performance context for Gain Therapeutics, Inc..

Financial health

Review financial health context for Gain Therapeutics, Inc..

Dividend

Review dividend context for Gain Therapeutics, Inc..

Management

Review management context for Gain Therapeutics, Inc..

Ownership

Review ownership context for Gain Therapeutics, Inc..

Other information

Review other information context for Gain Therapeutics, Inc..

Community

Review community context for Gain Therapeutics, Inc..